ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

CYCCP Cyclacel Pharmaceuticals Inc

6,51
-0,64 (-8,95%)
Zuletzt aktualisiert: 15:54:46
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cyclacel Pharmaceuticals Inc CYCCP NASDAQ Preference Share
  Änderung Änderung % Aktuell Zeit
-0,64 -8,95% 6,51 15:54:46
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,23 6,51 7,23 7,15
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.5.202415:56EDGAR2Form D - Notice of Exempt Offering of Securities
14.5.202423:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.5.202422:05EDGAR2Form 8-K - Current report
14.5.202422:05GLOBECyclacel Pharmaceuticals Reports First Quarter Financial..
13.5.202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08.5.202415:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
08.5.202403:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08.5.202403:52EDGAR2Form DEF 14A - Other definitive proxy statements
06.5.202423:26EDGAR2Form S-1 - General form for registration of securities under..
02.5.202422:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
30.4.202419:51APS$8 Million Private Placement Announcement Sends Biotech..
30.4.202413:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
01.4.202415:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
19.3.202421:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
13.3.202421:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
07.3.202415:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
06.3.202415:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
20.2.202415:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
14.2.202422:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.2.202416:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202421:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202423:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202415:15EDGAR2Form 8-K - Current report
30.1.202415:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
19.1.202422:58EDGAR2Form S-1 - General form for registration of securities under..
12.1.202422:05EDGAR2Form 8-K - Current report
10.1.202419:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.1.202422:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.1.202422:05EDGAR2Form 8-K - Current report
26.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202315:29EDGAR2Form 8-K - Current report
26.12.202315:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18.12.202315:00GLOBECyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
12.12.202322:06EDGAR2Form 8-K - Current report
12.12.202322:05GLOBECyclacel Pharmaceuticals Announces Reverse Stock Split
30.11.202315:15GLOBECyclacel Regains Compliance With Nasdaq Listing Rule..
29.11.202303:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29.11.202303:20EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28.11.202323:15GLOBECyclacel Receives Notification of Deficiency From Nasdaq..
28.11.202322:59EDGAR2Form 8-K - Current report
15.11.202323:04EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15.11.202323:03EDGAR2Form 8-K - Current report
13.11.202322:06EDGAR2Form 8-K - Current report
07.11.202322:10EDGAR2Form 8-K - Current report
07.11.202315:15GLOBECyclacel Pharmaceuticals to Release Third Quarter 2023..
02.11.202321:30EDGAR2Form PRE 14A - Other preliminary proxy statements
08.9.202322:10EDGAR2Form 8-K - Current report